Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct...
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals
About this item
Full title
Author / Creator
Lin, Chuan-Pin , Liang, Po-Cheng , Huang, Ching-I , Yeh, Ming-Lun , Hsu, Po-Yao , Hsu, Cheng-Ting , Wei, Yu-Ju , Liu, Ta-Wei , Hsieh, Ming-Yen , Hou, Nai-Jen , Jang, Tyng-Yuang , Lin, Yi-Hung , Wang, Chih-Wen , Lin, Zu-Yau , Chen, Shinn-Cherng , Huang, Chung-Feng , Huang, Jee-Fu , Dai, Chia-Yen , Chuang, Wan-Long and Yu, Ming-Lung
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Undetectable HCV RNA 12 weeks after the end of treatment (SVR12) has been the valid efficacy endpoint in the era of direct-acting antivirals (DAAs). Its concordance with SVR4 and SVR24 and long-term durability is unknown in Taiwanese chronic hepatitis C (CHC) patients.
A total of 1080 CHC patients who received all-oral DAAs and an achieved end-o...
Alternative Titles
Full title
Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2486455822
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2486455822
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0245479
